Is Zoetis Inc. (ZTS) Overvalued?
We dive into why Zoetis Inc. (ZTS) could be considered overvalued on 2026-07-17, based on AAII’s Value Score and Grade.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
Commentary & Analysis
Which Is a Better Investment, Pfizer Inc. or Zoetis Inc. Stock?
Learn more about whether Pfizer Inc. or Zoetis Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Michael Rose
Why Zoetis Inc.’s (ZTS) Stock Is Down 6.58%
As of Monday, May 11, Zoetis Inc.’s ZTS share price has dipped by 6.58%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Zoetis Inc.’s (ZTS) Stock Is Down 21.51%
As of Thursday, May 07, Zoetis Inc.’s ZTS share price has dipped by 21.51%, which has investors questioning if this is right time to buy.Michael Rose
Why Zoetis Inc.’s (ZTS) Stock Is Down 20.06%
As of Thursday, May 07, Zoetis Inc.’s ZTS share price has dipped by 20.06%, which has investors questioning if this is right time to buy.Omar Beirat
Financial Summary
| Share Statistics | ZTS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $32,402.1 | $579.1 | 90% |
|
| Shares Out (Mil) | 422.4 | 43.0 | 87% |
|
| Institutional Ownership | 99.9% | 84.3% | 96% |
|
| Float (Mil) | 418.4 | 46.8 | 84% |
|
| Beta | 0.86 | 0.62 | 51% |
|
| Avg Daily Volume (000s) | 5,148 | 285 | 92% |
|
| Price Change (52-week) |
(48.1%) | 63.8% | 16% |
|
| Growth | ZTS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 7.2% | 6.7% | 46% |
|
| Net Income (5yr) | 10.3% | (1.4%) | 55% |
|
| EPS (5yr) | 12.0% | 14.9% | 50 |
|
| Dividends (5yr) | 20.1% | 0.0% | 90% |
|
| Cash Flow (5yr) | (27.0%) | (14.9%) | 23% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 14 | 17 | 19 | |
| Current EPS | $1.852 | $6.862 | $7.392 | |
| Month Ago EPS | $1.861 | $6.873 | $7.394 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | $1.899 | $7.029 | $7.574 | |
| Year/Year Chg | 30.4% | 14.0% | 32.5% | |
| Financials | ZTS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $9,531 | $272 | 84% |
|
| Net Income (TTM) (Mil) | $2,672 | ($11) | 94% |
|
| EPS (TTM) | $6.113 | ($0.500) | 89% |
|
| Operating Cash Flow (TTM) (Mil) | $2,790 | ($6) | 91% |
|
| Net Cash Flow (TTM) (Mil) | $82 | $4 | 75% |
|
| Long-Term Debt (Q1) (Mil) | $9,254 | $7 | 91% |
|
| Enterprise Value (Q1) (Mil) | $40,881 | $522 | 90% |
|
| Valuation | ZTS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 10.05 | 2.73 | 90% |
|
| P/E | 12.7 | 20.5 | 27% |
|
| Dividend Yield | 2.7% | 0.0% | 82% |
|
| PEG (5yr hist) | 1.1 | 1.2 | 46% |
|
| Ratios | ZTS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 71.8% | 65.9% | 82% |
|
| Net Margin | 28.0% | 0.7% | 87% |
|
| ROA | 18.3% | (24.6%) | 95% |
|
| ROE | 67.7% | (19.7%) | 94% |
|
| Liabilities to Assets | 78.7% | 35.5% | 74% |
|
| F-Score | 8 | 3 | 94% |
|
Zoetis Inc. did not pass any screens on 7/31/2026.
